Andere Sprachen Dancann Pharma A/S

Aktien

DANCAN

DK0061410487

DANCAN

Schlusskurs NORDIC GROWTH MARKET Andere Börsenplätze 00:00:00 29.04.2024			% 5 Tage	% 1. Jan.
0,06 ^DKK	+7,14 %		+40,19 %	+100,00 %

29.03.	Dancann Pharma plant Bezugsrechtsemission im Wert von bis zu 19 Millionen DKK	MT
28.02.	DanCann Pharma nimmt die Legalisierung von Cannabis in Deutschland zur Kenntnis und lässt seine Aktien steigen	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

DanCann Pharma A/S: MINUTES OF EXTRAORDINARY GENERAL MEETING	17.04.
NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S	02.04.
Dancann Pharma Plans Up to DKK19 Million Rights Issue	29.03.
DanCann Pharma A/S intends to initiate and complete a partly secured rights issue of up to DKK 18.5 million to restructure, strengthen and secure a debt-free capital structure	29.03.
DanCann Pharma Notes Cannabis Legalization in Germany as Shares Surge	28.02.
DanCann Pharma A/S: Germany makes historic move towards cannabis reclassification and legalization	28.02.
DanCann Pharma A/S Reports Fourth Quarter and Full Year 2023 Results	28.02.
Dancann Pharma A/S Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28.02.
Dancann Pharma A/S Reports Earnings Results for the Full Year Ended December 31, 2023	28.02.
DanCann Pharma A/S Completes Issuance (8) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2	10.01.
DanCann Pharma A/S delivers annual shareholder letter and investor update	20.12.
Dancann Pharma A/S Provides Revenue Guidance for the Financial Year 2025	20.12.
DanCann Pharma A/S: Flagging announcement	30.11.
DanCann Pharma A/S publishes Q3-2023 report	30.11.
Dancann Pharma A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	30.11.
DanCann Pharma A/S Completes Issuance (7) of New Shares under the Loan-Agreement with Nordic Growth Opportunities 2 - Marking a Milestone with a Conversion Rate Exceeding 50 percent of Tranche 1	28.11.
DanCann Pharma Issues New Shares For Debt Conversion	23.11.
DanCann Pharma A/S Completes Issuance (6) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2	22.11.
DanCann Pharma A/S: Future strategic direction	26.10.23
DanCann Pharma Issues New Shares Following Debt Conversion	04.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Dancann Pharma A/S

Aktien

DANCAN

DK0061410487

DANCAN

Andere Sprachen

Filter